To assess the efficacy of two different treatment regimens of etanercept in psoriasis subjects with psoriatic arthritis with respect to both the skin and joint manifestations.
Official Title
A Randomized, Double-Blind, Two-Period Study to Evaluate the Safety and Efficacy of Etanercept on Skin and Joint Disease in Psoriasis Subjects With Psoriatic Arthritis.
Conditions
Study Type
Interventional
Study Design
Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Further Details
Currently Recruiting
Study Start
December 2005
Eligibility & Criteria
Ages Eligible for Study: 18 Years and above
Genders Eligible for Study: Both
Inclusion Criteria:
18 years of age or older at time of consent
Active Psoriatic Arthritis
Clinically stable, plaque psoriasis involving more than 10% of the body surface area
Exclusion Criteria:
Evidence of skin conditions other than psoriasis that would interfere with skin examinations.
Systemic anti-psoriasis therapy or DMARD within 28 days of study drug initiation
Prior exposure to any TNF-inhibitor, including etanercept.
Total Enrolment
800
Contact Details
Trial Manager: clintrialparticipation@wyeth.com
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
